title: Use of pattern recognition analysis to identify underlying relationships of Doxorubicin derivatives optimized for breast cancer treatment.
abstract: Introduction. Treatment of breast cancer includes surgery, drugs (hormone therapy and chemotherapy), and radiation. A discussion of eight drug constructs for the treatment of breast cancer, derived through application of in silico optimized molecular properties and substituent substitution, are analyzed using pattern recognition techniques. Methods and Materials. Determined properties of these eight compounds (inclusive of doxorubicin) showed a Log P varying from 0.567 to 4.137, rotatable bonds from 5 to 12, polar surface area from 195.1 A(2) to 206.1 A(2), and water solubility from 0.00873 mg/L to 390 mg/L. Analysis of similarity (ANOSIM), hierarchical cluster analysis, and neighbor-joining cluster analysis elucidated relationships among the drugs that are useful for pharmaceutical consideration. Results and Discussion. Although the new derivatives share the same parent scaffold (doxorubicin), elucidation by analysis of similarity (ANOSIM) indicates that these assorted compounds are substantially distinct. The number of oxygen and nitrogen atoms (hydrogen bond acceptors) remained constant at 12 for compounds. Although violations of the Rule of five remained constant at three for all compounds, the variation of Log P and water solubility offers potentially beneficial medicinal activity for this group of anticancer agents that may enhance the antitumor activity of these anthracycline antibiotics. Hierarchical cluster analysis results clearly differentiated the parent doxorubicin from all higher molecular weight analogs. This outcome is confirmed with the use of neighbor-joining cluster analysis. Conclusion. By utilizing in silico optimization with pattern recognition analysis, potentially advantageous analogs can be elucidated from known effective pharmaceuticals.
authors.affiliation: Chemistry Department, Durham Science Center, University of Nebraska at Omaha, 6001 Dodge Street, Omaha, NE 68182, USA.
authors.forename: Ronald
authors.initials: R
authors.lastname: Bartzatt
references.citation: Semin Oncol. 1992 Dec;19(6):670-86
references.pmid: 1462166
references.citation: Ann Oncol. 1999 Apr;10(4):403-11
references.pmid: 10370782
references.citation: Mol Biol Evol. 1987 Jul;4(4):406-25
references.pmid: 3447015
references.citation: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
references.pmid: 11259830
references.citation: BMC Med. 2010 Jan 07;8:3
references.pmid: 20055981
references.citation: Pharmacol Rev. 2004 Jun;56(2):185-229
references.pmid: 15169927
references.citation: J Clin Oncol. 2001 Jan 1;19(1):191-6
references.pmid: 11134212
references.citation: Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003917
references.pmid: 18425895
references.citation: Oncology. 2002;62(3):216-22
references.pmid: 12065868
references.citation: Forum (Genova). 2000 Oct-Dec;10(4):323-32
references.pmid: 11535983
references.citation: J Am Chem Soc. 2002 Mar 6;124(9):1871-6
references.pmid: 11866597
references.citation: Mol Interv. 2005 Jun;5(3):163-71
references.pmid: 15994456
references.citation: Semin Oncol. 1995 Dec;22(6 Suppl 15):13-7
references.pmid: 8643964